Rydapt Midostaurin — Carefirst Caremark
7 indications indexed for this drug.
- Acute Myeloid Leukemia AmlView coverage criteria
- Aggressive Systemic Mastocytosis AsmView coverage criteria
- Mast Cell Leukemia MclView coverage criteria
- Myeloid And Or Lymphoid Neoplasms With Eosinophilia And FgfrView coverage criteria
- Smoldering Systemic Mastocytosis SssmView coverage criteria
- Symptomatic Indolent Systemic Mastocytosis IsmView coverage criteria
- Systemic Mastocytosis With Associated Hematological NeoplasmView coverage criteria